These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27816435)

  • 1. A review of human biomonitoring data used in regulatory risk assessment under Canada's Chemicals Management Program.
    Zidek A; Macey K; MacKinnon L; Patel M; Poddalgoda D; Zhang Y
    Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):167-178. PubMed ID: 27816435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of human biomonitoring of environmental chemicals in the Canadian Health Measures Survey: 2007-2019.
    Haines DA; Saravanabhavan G; Werry K; Khoury C
    Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):13-28. PubMed ID: 27601095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of Health Canada's progress on human biomonitoring-based risk assessments and the path forward.
    Poddalgoda D; Macey K; Chander N; Jayawardene I; Sitland B; Mohr S; Hancock S
    Toxicol Lett; 2024 Aug; 399():19-24. PubMed ID: 38992804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of exposure to environmental chemicals in children and older adults using human biomonitoring data sorted by age: Results from a literature review.
    Choi J; Knudsen LE; Mizrak S; Joas A
    Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):282-298. PubMed ID: 28159478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of human biomonitoring data in a health risk based context: An updated analysis of population level data from the Canadian Health Measures Survey.
    Faure S; Noisel N; Werry K; Karthikeyan S; Aylward LL; St-Amand A
    Int J Hyg Environ Health; 2020 Jan; 223(1):267-280. PubMed ID: 31523017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiresidue analysis of environmental pollutants in edible vegetable oils by gas chromatography-tandem mass spectrometry.
    Zhou RZ; Jiang J; Mao T; Zhao YS; Lu Y
    Food Chem; 2016 Sep; 207():43-50. PubMed ID: 27080878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.
    Apel P; Lamkarkach F; Lange R; Sissoko F; David M; Rousselle C; Schoeters G; Kolossa-Gehring M
    Int J Hyg Environ Health; 2023 Mar; 248():114097. PubMed ID: 36577283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated exposure assessment of phthalates for the general population in China based on both exposure scenario and biomonitoring estimation approaches.
    Cao Y; Liu J; Liu Y; Wang J; Hao X
    Regul Toxicol Pharmacol; 2016 Feb; 74():34-41. PubMed ID: 26654930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
    Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
    Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
    Boogaard PJ; Aylward LL; Hays SM
    Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on the practical application of human biomonitoring in integrated environmental health impact assessment.
    Smolders R; Schramm KW; Stenius U; Grellier J; Kahn A; Trnovec T; Sram R; Schoeters G
    J Toxicol Environ Health B Crit Rev; 2009 Feb; 12(2):107-23. PubMed ID: 19235621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
    Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.
    St-Amand A; Werry K; Aylward LL; Hays SM; Nong A
    Toxicol Lett; 2014 Dec; 231(2):126-34. PubMed ID: 25455445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The added value of a surveillance human biomonitoring program: The case of FLEHS in Flanders (Belgium).
    Reynders H; Colles A; Morrens B; Mampaey M; Coertjens D; Koppen G; Schoeters G; Loots I; Chovanova H; Winderickx W; Van Campenhout K
    Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):46-54. PubMed ID: 27692571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing exposure to phthalates - the human biomonitoring approach.
    Wittassek M; Koch HM; Angerer J; Brüning T
    Mol Nutr Food Res; 2011 Jan; 55(1):7-31. PubMed ID: 20564479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.